Medicated Skin Care in Ireland

Date: June 12, 2012
Pages: 38
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M3C9CF01980EN
Leaflet:

Download PDF Leaflet

2011 proved to be a poor year for topical allergy remedies/antihistamines with lower than expected growth of 2% as a result of poor summer weather. The lower than usual temperatures resulted in less insects and contributed to fewer outdoor activities, resulting in fewer insect bites and stings, which negatively impacted both volume and value sales. Although late summer weather improved, especially during September and early October, this was not enough to compensate for the lost sales earlier...

Euromonitor International's Medicated Skin Care in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Pinewood Healthcare Group in Consumer Health (ireland)
Strategic Direction
Key Facts
  Summary 1 Pinewood Healthcare: Key Facts
Company Background
  Summary 2 Pinewood Healthcare Group: Production Statistics 2011
Competitive Positioning
  Summary 3 Pinewood Healthcare Group: Competitive Position 2011
Executive Summary
Consumer Health Remains Positive
New Guidance for OTC Paediatric Cough/cold Remedies for Children Under Six
Government Cuts Encourage OTC Sales
Pharmacy-led Sales Dominate Channels
Forecast Performance Expected To Be Muted
Key Trends and Development
Difficult Economic Conditions Persist
Your Health Is Your Wealth
Cost Cutting May Lead To Increased Switching
Value Remains Key for Consumers
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Prescription-only Classification
Controlled Drugs
OTC Consumer Health Products
Restrictions on the Sale of Acetaminophen Products
Restrictions on the Sale of Codeine Products
De-listing and De-reimbursement
Switching and Reimbursable Status
Advertising
Manufacturers Seek Greater Freedom in Advertising Prescription-only Products
Self-regulation
Packaging and Labelling
Distribution
Distance Selling Remains Prohibited, While Imports for Personal Use Remain Legal
Vitamins and Dietary Supplements Registration and Classification
Restrictions on the Sale of Products Containing Vitamin Or Mineral Ingredients
EU Legislation
Self-medication/self-care and Preventative Medicine
Generics
Switches
  Summary 4 OTC - Switches 2009-2011
Sources
  Summary 5 Research Sources
Skip to top


Medicated Skin Care in the US US$ 990.00 Apr, 2012 · 53 pages
Medicated Skin Care in Vietnam US$ 990.00 Aug, 2012 · 24 pages
Medicated Skin Care in Colombia US$ 990.00 May, 2012 · 35 pages
Medicated Skin Care in New Zealand US$ 990.00 Mar, 2012 · 36 pages
Medicated Skin Care in Venezuela US$ 990.00 Apr, 2012 · 30 pages

Ask Your Question

Medicated Skin Care in Ireland
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: